Skip to main content
Premium Trial:

Request an Annual Quote

Synamatix, Thermo Fisher Scientific, Epicentre Biotechnologies

Synamatix has launched two software products designed for analyzing data from next-generation sequencing instruments. The first, SXOligosearch, is designed to map short sequences such as reads from the Illumina Genome Analyzer or oligonucleotide microarray probes. The second is an updated version of the company’s SynaSearch sequence searching software that has been “modified to process and map reads from the GS20 and FLX platforms from 454,” the company said.

Thermo Fisher Scientific has released a new range of Verso cDNA synthesis kits and RT-PCR kits. The company said that the kits combine a new reverse transcription enzyme with improved priming options and optimized buffers to generate a high yield of full-length cDNA. The new enzyme, called Verso RT, has an improved dynamic range that maximizes sensitivity “and allows users to detect a wider range of starting template concentrations,” the company said.

Epicentre Biotechnologies has released MasterAmp Tfl DNA Polymerase, a recombinant DNA polymerase with thermostability to approximately 95 degrees Celcius. The kit includes betaine as part of the MasterAmp 10X PCR Enhancer, which improves the yield and specificity of amplification of many target sequences, especially those containing a high G+C content or secondary structure, Epicentre said. The company said that it also improves the yield consistency of PCR products in multiplex PCR reactions.
Epicentre also released ScriptGuard RNase Inhibitor, which is designed to protect RNA samples “even when trace amounts of RNase are present,” the company said. ScriptGuard RNase Inhibitor does not interfere with enzymes commonly used to prepare RNA and is “substantially” more resistant to inactivation by oxidation than other RNase inhibitors, Epicentre said.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.